U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07026513) titled 'ORal Aminaphtone and Combined LidocainE' on June 10.
Brief Summary: This observational study, called ORACLE (ORal Aminaphtone and Combined LidocainE), is being conducted at Treviso Regional Hospital (Italy) to evaluate the effectiveness of a first-line treatment for patients with internal hemorrhoidal disease (HD). The study focuses on a combination therapy using an oral drug, aminaphtone (Capillarema(R)), and a topical cream with lidocaine (Octosedan(R)), compared to standard conservative care.
Hemorrhoidal disease is a common condition that can cause bleeding, discomfort, itching, and swelling in the anal area. Many patients expe...